March 10, 2020 / 8:33 PM / 19 days ago

BRIEF-Chemocentryx Reports Qtrly Loss Per Share $0.26

March 10 (Reuters) - ChemoCentryx Inc:

* CHEMOCENTRYX REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

* Q4 REVENUE $10 MILLION VERSUS REFINITIV IBES ESTIMATE OF $9.7 MILLION

* QTRLY LOSS PER SHARE $0.26

* Q4 EARNINGS PER SHARE VIEW $-0.26 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below